Incretins
Tirzepatide
Quick profile: GIP/GLP-1 peptide analogue, purity ≥99%, certificate of analysis per batch on request.
| Purity | ≥99% by HPLC |
|---|---|
| CAS number | 2023788-19-2 |
| Molecular weight | 4813 g/mol |
| Molecular formula | C225H348N48O68 |
| Material class | 39-amino-acid peptide |
| Appearance | White to off-white lyophilized powder |
| Available sizes | 5mg · 10mg · 20mg · 30mg · 40mg · 50mg · 60mg · 100mg |
| Documentation | Certificate of analysis on request |
Tirzepatide is a modified GIP-sequence-based peptide with GLP-1 receptor activity and a lipid-linked side chain, presented as a research reference for receptor pharmacology, peptide stability and analytical method development.
The lipid side chain differs in chain length and attachment from the conjugation used in semaglutide, giving it a distinct, clearly separable retention behaviour on reversed-phase HPLC. At 39 residues and a molecular weight of 4813.0 g/mol, the molecule appears in mass spectrometry as a multiply charged ion series; the overall mass is determined by deconvoluting the individual signals.
Purity (≥99% by specification), CAS number 2023788-19-2 and formula C225H348N48O68 make up the specification; the certificate of analysis for each batch is available for the product on request.
Related products
| Catalog | CAS number | Molecular weight | Available sizes | ||
|---|---|---|---|---|---|
 | CagrilintideIncretins | 1415456-99-3 | 4409 g/mol (acetate) | 5mg · 10mg · 20mg | View details → |
 | CagriSemaIncretins | — | — | 5mg total · 10mg total · 20mg total | View details → |
 | RC10Incretins | — | — | 10mg total | View details → |
 | RetatrutideIncretins | 2381089-83-2 | 4731 g/mol | 10mg · 15mg · 20mg · 30mg · 40mg · 60mg | View details → |
 | RTT60Incretins | — | — | 60mg total | View details → |